Transatlantique Private Wealth’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$937K Sell
9,751
-31
-0.3% -$3.01K 0.29% 94
2025
Q3
$932K Sell
9,782
-106
-1% -$9.74K 0.3% 96
2025
Q2
$862K Sell
9,888
-5
-0.1% -$424 0.32% 93
2025
Q1
$889K Hold
9,893
0.35% 85
2024
Q4
$790K Hold
9,893
0.3% 96
2024
Q3
$891K Sell
9,893
-1,990
-17% -$167K 0.34% 88
2024
Q2
$925K Buy
11,883
+22
+0.2% +$1.8K 0.38% 71
2024
Q1
$1.02M Sell
11,861
-500
-4% -$42.7K 0.45% 72
2023
Q4
$999K Sell
12,361
-151
-1% -$11.5K 0.47% 67
2023
Q3
$970K Buy
12,512
+69
+0.6% +$5.78K 0.52% 61
2023
Q2
$1.1M Buy
12,443
+15
+0.1% +$1.29K 0.57% 53
2023
Q1
$986K Buy
12,428
+1,367
+12% +$111K 0.55% 54
2022
Q4
$849K Buy
11,061
+2,402
+28% +$195K 0.51% 60
2022
Q3
$699K Hold
8,659
0.47% 67
2022
Q2
$777K Buy
+8,659
New +$877K 0.54% 65

Other funds holding MDT

Transatlantique Private Wealth's MDT Position: Q4 2025 in Review

Transatlantique Private Wealth reduced its Medtronic (MDT) stake by 0.32% in Q4 2025, selling an estimated $3.01K and leaving 9,751 shares worth $937K. The position accounts for 0.29% of the portfolio, ranked #94.

Transatlantique Private Wealth first reported a position in MDT in Q2 2022 and has held it in 15 quarters since. The position peaked at $1.1M in Q2 2023. 2,304 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Transatlantique Private Wealth held 9,751 shares of Medtronic worth $937K as of Q4 2025.
  • Transatlantique Private Wealth sold 31 Medtronic shares in Q4 2025, an estimated $3.01K.
  • Medtronic made up 0.29% of Transatlantique Private Wealth's portfolio in Q4 2025, its #94 holding.
  • Transatlantique Private Wealth first reported a position in Medtronic in Q2 2022 and has held it in 15 quarters since.
  • Transatlantique Private Wealth's Medtronic position peaked at $1.1M in Q2 2023.
  • 2,304 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Transatlantique Private Wealth's 13F filing for Q4 2025, filed 10 Feb 2026.